Evidence map›Paper›PMID 35127146›Full record

ArticleActa naturae

A Sorbent with Synthetic Ligand for Removing Pro-atherogenic and Pro-inflammatory Components from Human Blood Plasma.

O A Dmitrieva, E D Ovchinnikova, E A Utkina, P A Levashov, O I Afanasieva, I Y Adamova, S N Pokrovsky

Open access · hybridAbstract read
In one paragraph

Article in Acta naturae. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

O A DmitrievaFederal State Budgetary Institution «National Medical Research Center of Cardiology» Ministry of Health of the Russian Federation, Moscow, 121552 Russia.
E D OvchinnikovaFederal State Budgetary Institution «National Medical Research Center of Cardiology» Ministry of Health of the Russian Federation, Moscow, 121552 Russia.
E A UtkinaFederal State Budgetary Institution «National Medical Research Center of Cardiology» Ministry of Health of the Russian Federation, Moscow, 121552 Russia.
P A LevashovLomonosov Moscow State University, Moscow, 119991 Russia.
O I AfanasievaFederal State Budgetary Institution «National Medical Research Center of Cardiology» Ministry of Health of the Russian Federation, Moscow, 121552 Russia.
I Y AdamovaFederal State Budgetary Institution «National Medical Research Center of Cardiology» Ministry of Health of the Russian Federation, Moscow, 121552 Russia.
S N PokrovskyFederal State Budgetary Institution «National Medical Research Center of Cardiology» Ministry of Health of the Russian Federation, Moscow, 121552 Russia.
National Medical Research Center of Cardiology · RULomonosov Moscow State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elevated levels of apoB-100 containing lipoproteins and markers of systemic inflammation are often observed in patients with cardiovascular diseases. The concentrations can be reduced by pharmacotherapy or extracorporeal treatment. The sorbent, which removes CRP and atherogenic lipoproteins, simultaneously reduces the bloodstream concentration of these components. The efficacy and selectivity of the designed sorbent were studied, desorption constants of CRP (K

Indexed as

atherogenic lipoproteinsatherosclerosisC-reactive proteinlipoprotein (a)therapeutic apheresis

Identifiers

PMID35127146
PMCPMC8807530
OpenAlexW4210754079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.